Navigating transformation requires agility across product development, supply chain strategy and sustainability commitments
GLP-1 and its therapeutic exploitation Glucagon-like peptide-1 (GLP-1) is a peptide hormone produced by specialised intestinal cells in response to food
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
However, Ozempic, Wegovy, and other GLP-1 agonists are administered via injection because their structure does not remain intact in the digestive tract, she explains
Others may be guided toward semaglutide if it aligns better with their health history or medication tolerance